Cheltenham, United Kingdom

Thomas Papa

This inventor holds 1 USPTO granted patent. Top assignee: Sanofi Pasteur Inc.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Papa. Retrieved from https://idiyas.com/inventor/thomas-papa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thomas Papa - Innovator in Vaccine Development

Introduction

Thomas Papa is a notable inventor based in Cheltenham, GB. He has made significant contributions to the field of vaccine development, particularly in the area of dengue and yellow fever vaccinations. His innovative approach aims to enhance the efficacy of immunization methods for these diseases.

Latest Patents

Thomas Papa holds a patent for a method involving the concomitant administration of a yellow fever vaccine and a tetravalent dengue vaccine. This invention is designed to induce a protective immune response against yellow fever by administering both vaccines simultaneously to a human subject. The tetravalent dengue vaccine comprises live attenuated dengue viruses of serotypes 1 to 4, which further supports the immune response against yellow fever.

Career Highlights

Thomas is currently associated with Sanofi Pasteur Inc., a leading company in the field of vaccines. His work focuses on developing innovative solutions to combat infectious diseases, showcasing his commitment to public health and safety.

Collaborations

Throughout his career, Thomas has collaborated with talented professionals such as Fernando Noriega and Betzana Zambrano. These partnerships have contributed to the advancement of vaccine research and development.

Conclusion

Thomas Papa's contributions to vaccine innovation, particularly in the area of dengue and yellow fever, highlight his dedication to improving global health outcomes. His work continues to pave the way for more effective vaccination strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…